前列腺癌的治疗方法主要包括临床观察,去势姑息疗法(ADT),前列腺癌根治术(RP),以及前列腺癌放射治疗。前两种方法不是前列腺癌治愈的有效方法,仅适用于那些年龄较大或对生存期望不是很高的患者。长期以来,前列腺癌根治术(RP)一直作为前列腺癌治疗的“金标准”。但对于前列腺癌根治术(RP)与前列腺癌放射治疗(RT)的疗效比较,一直以来未有相关研究。本文作者首先根据前列腺癌AJCC临床T分期、iPSA以及Gleason评分定义了两种风险组,即NCCN风险组和D’Amico风险组。通过参考大量文献及相关治疗中心的病历随访,比较了RP与RT的疗效及并发症情况。相关数据如下:作者通 Prostate cancer treatment mainly includes clinical observation, castration palliation (ADT), radical prostatectomy (RP), and radiation therapy of prostate cancer. The first two methods are not an effective cure for prostate cancer and are only available for those who are older or whose survival is not very high. Prostate cancer radical surgery (RP) has long been used as a “gold standard” for the treatment of prostate cancer. However, there have been no studies comparing the efficacy of radical prostatectomy (RP) with radiation therapy of prostate cancer (RT). The authors first defined two risk groups, the NCCN risk group and the D’Amico risk group, based on the clinical T stage, iPSA, and Gleason scores for the AJCC prostate cancer. By referring to a large number of literature and relevant medical records, the curative effects and complications of RP and RT were compared. The relevant data are as follows: Author pass